- Formulation re: Other
- Proven active form
- Brand IP Statement(s) re: (c), (TM), (SM)
- Sublinthion
Patented protection system
- Formula re: Contains
- Patented, reduced oral glutathione for vital support
- Formulation re: Other
- 230% greater blood ratios
- Formulation re: Other
- Proven stability
230% improvement
- FDA Statement of Identity
- Dietary Supplement
- Formulation re: Vegetarian/Vegan
- Vegan
- Formulation re: Does NOT Contain
- Non-GMO
- FDA Disclaimer Statement
- This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
- General Statements: All Other Content
- Product of France
- Brand IP Statement(s) re: (c), (TM), (SM)
- French patent #FR2972327
- Formulation re: Other
- In a published human study, Clinical Glutathione with Sublinthion reported a 230% improvement in healthy glutathione ratios compared to unprotected glutathione.
- General Statements: All Other Content
- Blood ratios of active glutathione to oxidized glutathione between day 1 and day 21 after supplementation.
Blood GSH/GSSG ratio compared to unprotected glutathione
- Formulation re: Does NOT Contain